Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous-Cell Lung Cancer 1Small Cell Lung Carcinoma 1Retinoblastoma 1Retinal Neoplasms 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Cancer Recurrent 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Bronchogenic 1Bronchial Neoplasms 1Advanced Non Small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 2liposomal doxorubicin 1Tocotrienols 1Platinum Compounds 1EP-100 membrane-disrupting peptide 1Carboplatin 1Bevacizumab 1AC 7700 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ovarian Cancer Recurrent × Platinum Compounds × Clear all
NCT07295132 2025-12-19

RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

Asan Medical Center

Phase 2 Not yet recruiting
160 enrolled
Gynecologic

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡